TTY Biopharm Company Limited

TTY Biopharm Company Limitedverified

4105.TWO

Price:

$83.5

Market Cap:

$20.76B

TTY Biopharm Company Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally. The company operates through Oncology Business Unit, Intensive Care Business Unit, Healthcare Business Unit, Export and CDMO Business Unit, and Other Business Unit segments. It offers oncology drugs under the Lipo-Dox, Lonsurf, UFUR, TS-1, Pexeda, Gemmis, Oxalip, Irino, Epicin, Tynen, Anazo, Folina, Thado, Andason, Ivic, Asadin, Leavdo, Painkyl, Megest, Episil, Otril, Zobonic, Yondelis, and Pemazyre names for anti-cancer and supplementary treatments. The company provides anti-infection drugs under the Brosym, Colimycin, Cubicin,...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2007-12-31

Stock Exchange

TWO

Ticker

4105.TWO

The Enterprise Value as of December 2025 (TTM) for TTY Biopharm Company Limited (4105.TWO) is 20.44B

According to TTY Biopharm Company Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 20.44B. This represents a change of 16.05% compared to the average of 17.61B of the last 4 quarters.

TTY Biopharm Company Limited (4105.TWO) Historical Enterprise Value (quarterly & annually)

How has 4105.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of TTY Biopharm Company Limited over the last ten years is 18.45B. The current 20.44B Enterprise Value has changed 10.98% with respect to the historical average. Over the past ten years (40 quarters), 4105.TWO's Enterprise Value was at its highest in in the December 2022 quarter at 20.25B. The Enterprise Value was at its lowest in in the March 2025 quarter at 16.83B.

Quarterly (TTM)
Annual

Average

18.45B

Median

18.19B

Minimum

16.98B

Maximum

20.25B

TTY Biopharm Company Limited (4105.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of TTY Biopharm Company Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 18.50%

Maximum Annual Enterprise Value = 20.25B

Minimum Annual Increase = -15.09%

Minimum Annual Enterprise Value = 16.98B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202417.09B-11.38%
202319.29B-4.76%
202220.25B18.50%
202117.09B0.61%
202016.98B-15.09%

TTY Biopharm Company Limited (4105.TWO) Average Enterprise Value

How has 4105.TWO Enterprise Value performed in the past?

The current Enterprise Value of TTY Biopharm Company Limited (4105.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

18.87B

5-year avg

18.14B

10-year avg

18.45B

TTY Biopharm Company Limited (4105.TWO) Enterprise Value vs. Peers

How is 4105.TWO’s Enterprise Value compared to its peers?

TTY Biopharm Company Limited’s Enterprise Value is greater than Grape King Bio Ltd (15.82B), greater than Handa Pharmaceuticals, Inc. (14.78B), greater than Synmosa Biopharma Corporation (17.85B), greater than YungShin Global Holding Corporation (15.18B), greater than Alar Pharmaceuticals Inc. (17.44B), greater than EirGenix Inc. (17.73B), greater than Standard Chem & Pharm Co. Ltd. (10.29B), greater than TaiMed Biologics Inc. (16.90B), less than Sunmax Biotechnology Co., Ltd. (20.94B), greater than ScinoPharm Taiwan, Ltd. (11.84B),

Build a custom stock screener for TTY Biopharm Company Limited (4105.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TTY Biopharm Company Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

TTY Biopharm Company Limited (4105.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like TTY Biopharm Company Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is TTY Biopharm Company Limited's Enterprise Value?

What is the highest Enterprise Value for TTY Biopharm Company Limited (4105.TWO)?

What is the 3-year average Enterprise Value for TTY Biopharm Company Limited (4105.TWO)?

What is the 5-year average Enterprise Value for TTY Biopharm Company Limited (4105.TWO)?

How does the current Enterprise Value for TTY Biopharm Company Limited (4105.TWO) compare to its historical average?